NZ295907A - Method of growing enteric bacteria with enhanced immunogenicity - Google Patents

Method of growing enteric bacteria with enhanced immunogenicity

Info

Publication number
NZ295907A
NZ295907A NZ295907A NZ29590795A NZ295907A NZ 295907 A NZ295907 A NZ 295907A NZ 295907 A NZ295907 A NZ 295907A NZ 29590795 A NZ29590795 A NZ 29590795A NZ 295907 A NZ295907 A NZ 295907A
Authority
NZ
New Zealand
Prior art keywords
bactenum
enteric
entenc
bacterium
bacteria
Prior art date
Application number
NZ295907A
Other languages
English (en)
Inventor
John L Pace
Richard I Walker
Steven M Frey
Original Assignee
Microcarb Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/538,543 external-priority patent/US5681736A/en
Application filed by Microcarb Inc filed Critical Microcarb Inc
Publication of NZ295907A publication Critical patent/NZ295907A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/105Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/107Vibrio
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/045Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18Testing for antimicrobial activity of a material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55555Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NZ295907A 1994-10-05 1995-10-04 Method of growing enteric bacteria with enhanced immunogenicity NZ295907A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US31840994A 1994-10-05 1994-10-05
US08/538,543 US5681736A (en) 1994-10-05 1995-10-03 Methods for producing enhanced antigenic shigella bacteria and vaccines comprising same
US08/538,545 US5679564A (en) 1994-10-05 1995-10-03 Methods for producing enhanced antigenic campylobacter bacteria and vaccines
PCT/US1995/013196 WO1996011258A1 (fr) 1994-10-05 1995-10-04 Procedes de production de bacteries enteriques antigenes ameliorees et vaccins les contenant

Publications (1)

Publication Number Publication Date
NZ295907A true NZ295907A (en) 1999-04-29

Family

ID=27405987

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ295907A NZ295907A (en) 1994-10-05 1995-10-04 Method of growing enteric bacteria with enhanced immunogenicity

Country Status (16)

Country Link
EP (1) EP0804542A4 (fr)
JP (1) JP3394047B2 (fr)
CN (1) CN1168693A (fr)
AU (1) AU704283B2 (fr)
BR (1) BR9509276A (fr)
CA (1) CA2202027A1 (fr)
CZ (1) CZ104397A3 (fr)
FI (1) FI971403L (fr)
HU (1) HUT77876A (fr)
IL (1) IL115521A0 (fr)
MX (1) MX9702431A (fr)
NO (1) NO971519L (fr)
NZ (1) NZ295907A (fr)
PL (1) PL182700B1 (fr)
SG (2) SG73510A1 (fr)
WO (1) WO1996011258A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0792347B1 (fr) * 1994-10-05 2005-11-23 Antex Biologics, Inc. Methodes de production d'helicobacter sp. antigene ameliore et de vaccins le contenant
EP2327720A1 (fr) * 2003-05-30 2011-06-01 Intercell AG Antigènes d'entérocoque
US20100074846A1 (en) * 2006-03-17 2010-03-25 Ellis John A Campylobacter Vaccines and Methods of use
EP2161035B1 (fr) * 2007-05-28 2019-08-21 Daiichi Sankyo Company, Limited Composition de vaccin à cellules entières contenant bordetella parapertussis
CN107513553B (zh) * 2017-09-18 2021-05-18 江南大学 一种筛选具有拮抗空肠弯曲杆菌感染功能的乳酸菌的方法
CN109633151B (zh) * 2018-12-26 2022-03-11 西北农林科技大学 一种肠炎沙门氏菌检测方法、试纸条及应用
WO2020141103A1 (fr) 2018-12-31 2020-07-09 Bellevacc As Vaccin bactérien

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI932248L (fi) * 1991-09-18 1993-07-02 Amgen Inc Hepatit b-vaccinkomposition innehaollande ett gallsyrasalt

Also Published As

Publication number Publication date
CZ104397A3 (cs) 1998-06-17
NO971519D0 (no) 1997-04-03
CA2202027A1 (fr) 1996-04-18
PL182700B1 (pl) 2002-02-28
EP0804542A1 (fr) 1997-11-05
SG73510A1 (en) 2000-06-20
AU3956195A (en) 1996-05-02
EP0804542A4 (fr) 1998-10-28
WO1996011258A1 (fr) 1996-04-18
JPH10507347A (ja) 1998-07-21
FI971403A0 (fi) 1997-04-04
FI971403A7 (fi) 1997-06-04
JP3394047B2 (ja) 2003-04-07
HUT77876A (hu) 1998-09-28
AU704283B2 (en) 1999-04-15
SG73509A1 (en) 2000-06-20
PL319580A1 (en) 1997-08-18
CN1168693A (zh) 1997-12-24
BR9509276A (pt) 1997-11-18
IL115521A0 (en) 1996-06-18
NO971519L (no) 1997-05-27
FI971403L (fi) 1997-06-04
MX9702431A (es) 1998-05-31

Similar Documents

Publication Publication Date Title
US5858352A (en) Vaccine containing a Shigella bacterium having an enhanced antigenic property
Law Adhesion and its role in the virulence of enteropathogenic Escherichia coli
Robbins et al. Hypothesis for vaccine development: protective immunity to enteric diseases caused by nontyphoidal salmonellae and shigellae may be conferred by serum IgG antibodies to the O-specific polysaccharide of their lipopolysaccharides
Ørskov et al. 4 serotyping of Klebsiella
Nataro et al. Diarrheagenic escherichia coli
US6051416A (en) Methods for producing enhanced antigenic Helicobacter sp.
WO1996011257A9 (fr) Methodes de production d'helicobacter sp. antigene ameliore et de vaccins le contenant
NZ295907A (en) Method of growing enteric bacteria with enhanced immunogenicity
WO1996011258A9 (fr) Procedes de production de bacteries enteriques antigenes ameliorees et vaccins les contenant
Svenungsson et al. Synthetic disaccharide-protein antigens for production of specific 04 and 09 antisera for immunofluorescence diagnosis of Salmonella
Aziz Annotated bibliography on classical vibrio cholerae
Oranje Serological diagnosis of gonorrhoea using gonococcal pili as antigen
Lockman Motility and adherence as Salmonella typhimurium virulence factors: The pathogenesis of fla, mot, andfim mutants in murine typhoid fever
HM A Comparative Study of Typhidot-M with Widal and Blood Culture in Diagnosis of Typhoid Fever in Children
Cohen Operation of a Research Unit for Surveillance of Infectious Diseases and Development of Vaccines.
HK1005247A (en) Methods for producing enhanced antigenic enteric bacteria and vaccines comprising same
KARNATAKA Typing of Fecal Escherichia coli by Different Methods
Kim Studies on Salmonella enteritidis: Epidemiologic, diagnostic, and prophylactic approaches to S. enteritidis infection
Rashed Comparison of Lipopolysaccharide (LPS) specific IgA and IgG avidity maturation between Vivotif Vaccinees and naturally infected enteric patients in Bangladesh
Li Immunological identification and biochemical characterization of serotype-specific antigens of Yersinia enterocolitica using monoclonal antibodies

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)